Pfizer and Moderna seek authorization of omicron booster for kids ages 5-11
Paul Offit of the Perelman School of Medicine says that uncertain benefits for children and lack of historical data on bivalent vaccines might not justify pediatric authorizations for omicron boosters.
・ From NPR